Direct link to this page: http://www.hta.ac.uk/1031

Details of HTA journal title

Last updated: 31 August 2010 - Next update due: 7 September 2010

Research type:

Primary Research (e.g. trial) 

Title (lead author) etc:

A randomised controlled trial examining the longer-term outcomes of standard versus new antiepileptic drugs The SANAD trial  (Marson) 145 pages, Volume 11, number 37

DOI

10.3310/hta11370
|  View/print executive summary
|  View/print abstract
|  View full text in pdf format (1386 KB)

| Buy a printed version of this title - cost £20.00 each. [How to order]

# This title is available on our CD-ROM of the journal.
| Order a CD-ROM - free of charge worldwide.
#  Go to our correspondence page to comment on this publication  
Outputs in journals arising from this project

Headline:

Trial provides evidence that lamotrigine may be a clinical and cost-effective alternative to the existing standard drug treatment, carbamazepine, for epilepsy patients diagnosed as having partial seizures. 

Project ref:

95/13/01 

Original project title:

A randomised controlled trial of longer-term clinical outcomes and cost-effectiveness of standard and new antiepileptic drugs (SANAD) 

Chief Investigator:

Professor David Chadwick, Professor of Neurology, Dept of Neurological Science, The Walton Centre for Neurology and Neurosurgery

Project Website

http://www.liv.ac.uk/neuroscience/sanad

Start Date:

September 1998  

Date of publication in HTA journal series

October 2007

Cost:

£1,349,657 

MeSH* index primary terms:

EPILEPSY Q-drug-therapy; ANTICONVULSANTS Q-therapeutic-use (* = Medical Subject Headings)

MeSH* index secondary terms:

RANDOMIZED-CONTROLLED-TRIAL; CLINICAL-TRIAL; FOLLOW-UP-STUDIES; CARBAMAZEPINE Q-therapeutic-use; VALPROIC-ACID Q-therapeutic-use; COST-BENEFIT-ANALYSIS; TREATMENT-OUTCOME; HUMAN; COMPARATIVE-STUDY  (* = Medical Subject Headings)

ISRCTN* number:

ISRCTN 38354748 (*International Standard Randomised Controlled Trial Number) 
URL of this project on the Controlled Trials Website:
http://www.controlled-trials.com/ISRCTN38354748 

NRR* number, if applicable:

N0484070422 (*National Research Register) The National Research Register was a public database of ongoing and recently completed research projects funded by, or of interest to, the United Kingdom's National Health Service (NHS). It is now an archive of projects from early 2000 to September 2007. Search the NRR archive.

Project Protocol:

Project protocol not available

Printed copies of this title despatched:

119 (Figures relate to the previous calendar month)

Downloads/Views of electronic version from website:

44146 (Figures are cumulative.) Last updated 27th July 2010.

URL of this page:

http://www.hta.ac.uk/1031

Outputs from this project

  • Marson, A; Al-Kharusi, A; Alwaidh, M; Appleton, R; Baker, G; Chadwick, D; Cramp, C; Cockerell, O; Cooper, P; Doughty, J; Eaton, B; Gamble, C; Goulding, P; Howell, S; Hughes, A; Jackson, M; Jacoby, A; Kellett, M; Lawson, G; Leach, J; Nicolaides, P; Roberts, R; Shackley, P; Shen, J; Smith, P; Smith, P; Tudur Smith, C; Vanoli, A; Williamson, P. The SANAD study of effectiveness of valproate, lamotrigine, or topiramate for generalised and unclassifiable epilepsy: an unblinded randomised controlled trial. Lancet.
  • Marson, A; Al-Kharusi, A; Alwaidh, M; Appleton, R; Baker, G; Chadwick, D; Cramp, C; Cockerell, O; Cooper, P; Doughty, J; Eaton, B; Gamble, C; Goulding, P; Howell, S; Hughes, A; Jackson, M; Jacoby, A; Kellett, M; Lawson, G; Leach, J; Nicoladides, P; Roberts, R; Shackley, P; Shen, J; Smith, D; Smith, P; Tudur Smith, C; Vanoli, A; Williamson, P. The SANAD study of effectiveness of carbamazepine, gabapentine, lamotrigine, oxcarbazepine or topiramate for treatment of partial epilepsy: an unblinded randomised controlled trial. Lancet.
Tue, 31 Aug 2010 16:14:08 +0100

Advanced search How to use the search function